A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-11-27
DOI
10.1093/rheumatology/kez623
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutrophil extracellular trap formation is intrinsically distinct in ANCA ‐associated vasculitis and systemic lupus erythematosus
- (2019) Laura S. van Dam et al. Arthritis & Rheumatology
- Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors
- (2018) Tobias Alexander et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B-cell immunomics approach
- (2018) Christopher M. Tipton et al. IMMUNOLOGICAL REVIEWS
- The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus
- (2018) Tineke Kraaij et al. JOURNAL OF AUTOIMMUNITY
- B-cell therapy in lupus nephritis: an overview
- (2018) Salem Almaani et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A novel method for high-throughput detection and quantification of neutrophil extracellular traps reveals ROS-independent NET release with immune complexes
- (2016) Tineke Kraaij et al. AUTOIMMUNITY REVIEWS
- Plasma cells as an innovative target in autoimmune disease with renal manifestations
- (2016) Falk Hiepe et al. Nature Reviews Nephrology
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients
- (2015) Gal Yaniv et al. AUTOIMMUNITY REVIEWS
- Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways
- (2015) Sophia Thanei et al. CLINICAL IMMUNOLOGY
- Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis
- (2015) Jürgen Dieker et al. MOLECULAR IMMUNOLOGY
- Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus
- (2015) Christopher M Tipton et al. NATURE IMMUNOLOGY
- Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
- (2015) Till Fassbinder et al. ARTHRITIS RESEARCH & THERAPY
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoantibodies from long-lived ‘memory’ plasma cells of NZB/W mice drive immune complex nephritis
- (2013) Qingyu Cheng et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity
- (2013) Sladjana Andrejevic et al. CLINICAL RHEUMATOLOGY
- Immune Complex Signatures of Patients with Active and Inactive SLE Revealed by Multiplex Protein Binding Analysis on Antigen Microarrays
- (2012) Krisztián Papp et al. PLoS One
- B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levels
- (2012) Mark N. Lazarus et al. RHEUMATOLOGY
- B cell biomarkers of rituximab responses in systemic lupus erythematosus
- (2011) Edward M. Vital et al. ARTHRITIS AND RHEUMATISM
- Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus
- (2011) R. Lande et al. Science Translational Medicine
- Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus
- (2011) G. S. Garcia-Romo et al. Science Translational Medicine
- Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus
- (2010) C. C. van Bavel et al. ANNALS OF THE RHEUMATIC DISEASES
- Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares
- (2010) A Matrat et al. LUPUS
- Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study
- (2009) Annett M. Jacobi et al. ARTHRITIS AND RHEUMATISM
- Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
- (2009) David Isenberg et al. RHEUMATOLOGY
- Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis
- (2009) Maria Rehnberg et al. ARTHRITIS RESEARCH & THERAPY
- Systemic Lupus Erythematosus
- (2008) Anisur Rahman et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started